This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yao, V. Articles by Bacich, D. J. Search for Related Content PubMed PubMed Citation Articles by Yao, V. Articles by Bacich, D. J.

Moderate Expression of Prostate-Specific Membrane Antigen, a Tissue Differentiation Antigen and Folate Hydrolase, Facilitates Prostate Carcinogenesis

Departments of ¹ Urology and ² Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania; ³ Mathematics Department, Indiana University of Pennsylvania, Indiana, Pennsylvania; and ⁴ Department of Cancer Biology, Lerner Research Institute, Cleveland, Ohio

Requests for reprints: Dean J. Bacich, University of Pittsburgh Medical Center Shadyside, Department of Urology, 5200 Centre Avenue, Suite G-32, Pittsburgh, PA 15232. Phone: 412-623-3913; Fax: 412-623-3907; E-mail: bacichdj{at}upmc.edu.

Key Words: PSMA • prostate • recombination • folate • invasion

Increased expression of PSMA, a differentiation antigen with folate hydrolase activity, is an independent marker of prostate cancer progression. Mice expressing moderate levels of human PSMA in their prostate develop PIN-like lesions by 9 months. The aim of this study was to determine whether PSMA is involved in prostate carcinogenesis and progression and, if so, the possible mechanism by which PSMA may exert its effects. Using prostates from PSMA-transgenic mice, we developed a tissue recombinant model that exhibits small atypical glands with features of adenocarcinoma. This was not observed in tissue recombinants that were composed of prostate tissues from the wild-type siblings. Cells from PSMA-transgenic tissue recombinants have the ability to form colonies in semisolid agar. PSMA may facilitate this phenotype by increasing the invasive ability of cells. Ectopic PSMA expression on PC-3 cells increased the invasive capacity of cells in in vitro invasion assays, which could be competed out by folic acid. These results suggest PSMA facilitates the development of prostate cancer, and the invasive ability of these cells may be modulated by folate levels. These findings show a novel mechanism that may contribute to the known role of folate in cancer prevention, and may lead to the use of PSMA inhibitors as novel chemopreventive agents for prostate cancer. Moreover, our model should prove useful for further dissecting pathways involved in prostate carcinogenesis and progression. [Cancer Res 2008;68(21):9070–7]

This article has been cited by other articles:

				S. M. Hillier, K. P. Maresca, F. J. Femia, J. C. Marquis, C. A. Foss, N. Nguyen, C. N. Zimmerman, J. A. Barrett, W. C. Eckelman, M. G. Pomper, et al. Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer Cancer Res., September 1, 2009; 69(17): 6932 - 6940. [Abstract] [Full Text] [PDF]